Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Nuvectis Pharma, Inc. (NVCT) had Return on Investments of -143.61% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-28.87M |
|
-- |
|
-- |
|
$27.57M |
|
$-27.57M |
|
$1.13M |
|
$-26.44M |
|
$-26.44M |
|
$-26.44M |
|
$-26.44M |
|
$-26.44M |
|
$-26.44M |
|
$-27.57M |
|
$-27.57M |
|
21.81M |
|
21.81M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$31.71M |
|
-- |
|
-- |
|
$31.71M |
|
$13.30M |
|
-- |
|
-- |
|
$13.30M |
|
$18.41M |
|
$18.41M |
|
$18.41M |
|
25.68M |
|
| Cash Flow Statement Financials | |
$-16.01M |
|
-- |
|
$29.11M |
|
$18.53M |
|
$31.63M |
|
$13.10M |
|
$6.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-143.60% |
|
-143.61% |
|
-83.39% |
|
|
Return on Investments |
-143.61% |
$0.72 |
|
$-0.73 |
|
$-0.73 |
|